Geode Capital Management LLC Raises Stake in Sotera Health (NASDAQ:SHC)

Geode Capital Management LLC boosted its holdings in Sotera Health (NASDAQ:SHC) by 0.9% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,780,445 shares of the company’s stock after purchasing an additional 25,054 shares during the quarter. Geode Capital Management LLC owned about 0.98% of Sotera Health worth $38,048,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Vanguard Group Inc. boosted its position in shares of Sotera Health by 1.2% in the 4th quarter. Vanguard Group Inc. now owns 14,923,546 shares of the company’s stock worth $204,154,000 after purchasing an additional 173,341 shares in the last quarter. State Street Corp raised its stake in Sotera Health by 18.5% during the third quarter. State Street Corp now owns 4,126,806 shares of the company’s stock valued at $68,918,000 after buying an additional 644,236 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in Sotera Health by 45.1% in the fourth quarter. Bank of New York Mellon Corp now owns 1,630,736 shares of the company’s stock worth $22,308,000 after acquiring an additional 507,147 shares in the last quarter. Norges Bank purchased a new stake in shares of Sotera Health in the fourth quarter worth $12,764,000. Finally, Barclays PLC grew its stake in shares of Sotera Health by 169.8% in the third quarter. Barclays PLC now owns 473,597 shares of the company’s stock worth $7,909,000 after acquiring an additional 298,085 shares during the last quarter. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Barclays dropped their price target on shares of Sotera Health from $16.00 to $12.00 and set an “overweight” rating on the stock in a research note on Thursday, April 10th. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $15.20.

Sotera Health Trading Down 1.1 %

Shares of NASDAQ:SHC opened at $10.50 on Wednesday. Sotera Health has a 1 year low of $9.53 and a 1 year high of $17.08. The stock’s fifty day moving average price is $12.02 and its 200-day moving average price is $13.44. The company has a market cap of $2.98 billion, a P/E ratio of 42.00 and a beta of 1.88. The company has a debt-to-equity ratio of 4.91, a current ratio of 2.88 and a quick ratio of 2.61.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.